BE PART OF THE SOLUTION FOR
COLORECTAL CANCER
BLADDER CANCER
PROSTATE CANCER
PANCREATIC CANCER
LUNG CANCER
We help cancer patients by collecting their medical records from providers and analyzing them to find the right clinical trials and insights into tumor mutations and treatments, finding medical oncologists for second opinions, and supporting medical research to find the cures for tomorrow by improving outcomes for those cancer patients enrolling in clinical trials – free of charge for cancer patients.
BE PART OF THE SOLUTION FOR
BOWEL CANCER
BLADDER CANCER
PROSTATE CANCER
PANCREATIC CANCER
LUNG CANCER
We help cancer patients by collecting their medical records from providers and analyzing them to find the right clinical trials and insights into tumor mutations and treatments, finding medical oncologists for second opinions, and supporting medical research to find the cures for tomorrow by improving outcomes for those cancer patients enrolling in clinical trials – free of charge for cancer patients.
WHY ARE WE DOING THIS?
Our team at BioXplor is backed by UC Berkeley Skydeck and the European Commission’s Innovation Council and has been working with medical research and clinical development teams for nearly 5 years now. We have helped bring about 4 new clinical trials and validated a novel cancer drug combination in the laboratory. More recently our family, friends, and neighbours have been affected by cancer during the pandemic, so we decided to analyze one patient’s medical records to run against our databases to find information on clinical trials, mutations, side effects, and second opinions.
We found strong clinical evidence supporting a powerful approved drug and a surgical clinical trial matched to the patient’s medical data, which were completely unknown to the patient’s medical team. These insights are now being implemented into the patient’s treatment plan. We also found insights on treatment side effects and solutions and medical oncologists for second opinions with insights into their research output and specialty from medical literature. That is the reason why we have decided to develop the ONCOCORE software tool so as to empower many more cancer patients with these important insights and to share them with their medical teams.
To find these insights we need to analyze the patient’s medical data and we learned how difficult it is for cancer patients to access their medical records from different hospitals and laboratories, in addition to finding matching clinical trials, the right doctor for a second opinion, and to understand tumor mutation and side effect insights. So our solution is to both collect that data and provide the insights to you, and in exchange for this, you will be supporting a bigger mission to improve cancer patient outcomes through research studies to find the right treatments for the right patient by including your anonymized data in aggregate with other patient’s data for clinical development and outcomes research in cancer.
PRE-REGISTER FOR EARLY ACCESS
WHAT WE PROVIDE TO YOU
CLINICAL TRIALS RECRUITING
Phase 3 Trials
Colon Cancer
80 clinical trials actively recruiting.
Phase 2 Trials
Colon Cancer
306 clinical trials actively recruiting.
Phase 1 Trials
Colon Cancer
238 clinical trials actively recruiting.
Phase 3 Trials
Bladder Cancer
38 clinical trials actively recruiting.
Phase 2 Trials
Bladder Cancer
119 clinical trials actively recruiting.
Phase 1 Trials
Bladder Cancer
92 clinical trials actively recruiting.
Phase 3 Trials
Prostate Cancer
91 clinical trials actively recruiting.
Phase 2 Trials
Prostate Cancer
331 clinical trials actively recruiting.
Phase 1 Trials
Prostate Cancer
210 clinical trials actively recruiting.
Phase 3 Trials
Pancreatic Cancer
33 clinical trials actively recruiting.
Phase 2 Trials
Pancreatic Cancer
236 clinical trials actively recruiting.
Phase 1 Trials
Pancreatic Cancer
202 clinical trials actively recruiting.
Phase 3 Trials
Lung Cancer
162 clinical trials actively recruiting.
Phase 2 Trials
Lung Cancer
750 clinical trials actively recruiting.
Phase 1 Trials
Lung Cancer
538 clinical trials actively recruiting.